Form 4 for ANNX Annexon, Inc.
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-16 · accession 0001415889-24-004627 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-21 | 2024-02-16 | ANNX | Dananberg Jamie | Chief MEDICAL Off | A - Grant | $0.00 | +39.0K | 39.0K | New | $0 |
| D | 2024-02-21 | 2024-02-16 | ANNX | Dananberg Jamie | Chief MEDICAL Off | A - Grant | $0.00 | +160.0K | 160.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-16 | A | A | 39,000 | $0.00 | 39,000 | D | — | — | (F1) Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 16 of each year, with the first 1/3rd vesting on February 16, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-02-16 | A | A | 160,000 | $0.00 | 160,000 | D | $5.13 · — to 2034-02-16 | 160,000 Common Stock | (F2) 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 16, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |